Cambridge, United Kingdom

Mladen Vinkovic



 

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Mladen Vinkovic: Innovator in Pharmaceutical Chemistry

Introduction

Mladen Vinkovic is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of six patents. His work focuses on developing innovative compounds that have potential medical applications.

Latest Patents

One of Vinkovic's latest patents is for Hydrobenzamide derivatives as inhibitors of Hsp90. This invention provides an acid addition salt of a compound of a specific formula. It also includes processes for preparing the compound and its alkyl analogs, along with novel intermediates for use in the process. Additionally, the invention outlines new medical uses for these compounds. Another notable patent involves pyrazole compounds that modulate the activity of CDK, GSK, and aurora kinases. This invention details a compound of a specific formula and includes pharmaceutical compositions, processes for making the compounds, and their use in treating diseases mediated by specific kinases.

Career Highlights

Mladen Vinkovic is currently associated with Astex Therapeutics Limited, where he continues to advance his research and development efforts. His work has been pivotal in creating new therapeutic options in the pharmaceutical industry.

Collaborations

Vinkovic has collaborated with notable colleagues such as Paul Graham Wyatt and David Charles Rees, contributing to a dynamic research environment that fosters innovation.

Conclusion

Mladen Vinkovic's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for new medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…